Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

The ​Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.

According to Nuvama, the increased competitive intensity following this approval is negative for Cipla, as it raises the risk ...

The price of semaglutide drugs could drop by more than 65% when generic versions of Ozempic and Wegovy hit shelves — possibly ...

The Food and Drug Administration on Monday announced it had approved generic versions of Vyvanse, an increasingly popular alternative to Adderall. Commonly prescribed ...

We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of ...

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...

The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...

The Food and Drug Administration approved the first direct generic competitor to the EpiPen on Thursday, setting the stage for cheaper competition that may lower prices. The new generic, which won’t ...

Officials with the FDA have approved the first generic robenacoxib tablets for the control of postoperative pain and ...